Gerd Ritter

2.0k total citations
15 papers, 948 citations indexed

About

Gerd Ritter is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Gerd Ritter has authored 15 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Gerd Ritter's work include Monoclonal and Polyclonal Antibodies Research (11 papers), Glycosylation and Glycoproteins Research (7 papers) and Immunotherapy and Immune Responses (4 papers). Gerd Ritter is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), Glycosylation and Glycoproteins Research (7 papers) and Immunotherapy and Immune Responses (4 papers). Gerd Ritter collaborates with scholars based in United States, United Kingdom and Australia. Gerd Ritter's co-authors include Lloyd J. Old, Achim A. Jungbluth, Leonard Cohen, Sydney Welt, Polly Roy, Akio Fukusho, Elisabeth Stockert, Andrew M. Scott, P O Livingston and Nancy E. Kemeny and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Gerd Ritter

15 papers receiving 920 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerd Ritter United States	13	443	429	302	269	120	15	948
Nicholas F. Landolfi United States	18	742 1.7×	792 1.8×	712 2.4×	234 0.9×	40 0.3×	30	1.6k
June Kan‐Mitchell United States	24	322 0.7×	792 1.8×	1.2k 4.0×	573 2.1×	57 0.5×	54	1.8k
Chiung-Chi Kuo United States	16	417 0.9×	561 1.3×	525 1.7×	179 0.7×	57 0.5×	21	1.4k
Alexander Filatov Russia	15	271 0.6×	386 0.9×	342 1.1×	140 0.5×	20 0.2×	68	902
Naveen Dakappagari United States	18	191 0.4×	430 1.0×	542 1.8×	292 1.1×	50 0.4×	32	919
Kandasamy Hariharan United States	17	348 0.8×	286 0.7×	467 1.5×	292 1.1×	48 0.4×	36	1.1k
H. Perry Fell United States	19	369 0.8×	416 1.0×	672 2.2×	341 1.3×	34 0.3×	25	1.2k
Antje Neumann Germany	15	109 0.2×	638 1.5×	933 3.1×	603 2.2×	84 0.7×	27	1.4k
Thomas Beyer Germany	18	498 1.1×	489 1.1×	780 2.6×	309 1.1×	77 0.6×	28	1.3k
Günther Heinrich United States	11	513 1.2×	905 2.1×	621 2.1×	158 0.6×	73 0.6×	12	1.6k

Countries citing papers authored by Gerd Ritter

Since Specialization

Citations

This map shows the geographic impact of Gerd Ritter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerd Ritter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerd Ritter more than expected).

Fields of papers citing papers by Gerd Ritter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerd Ritter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerd Ritter. The network helps show where Gerd Ritter may publish in the future.

Co-authorship network of co-authors of Gerd Ritter

This figure shows the co-authorship network connecting the top 25 collaborators of Gerd Ritter. A scholar is included among the top collaborators of Gerd Ritter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerd Ritter. Gerd Ritter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Carrasquillo, Jorge A., Neeta Pandit‐Taskar, Joseph A. O’Donoghue, et al.. (2011). ¹²⁴I-huA33 Antibody PET of Colorectal Cancer. Journal of Nuclear Medicine. 52(8). 1173–1180. 72 indexed citations

Yuan, Jianda, David B. Page, Geoffrey Y. Ku, et al.. (2010). Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy.. PubMed. 10. 1–1. 36 indexed citations

Damasceno, Leonardo M., Frank Lee, Gerd Ritter, Lloyd J. Old, & Carl A. Batt. (2009). High-Level Expression of a Phage Display-Derived scFv in Pichia pastoris. Methods in molecular biology. 562. 225–236. 9 indexed citations

Deckert, P. Markus, William G. Bornmann, Gerd Ritter, et al.. (2004). Specific tumour localisation of a huA33 antibody - carboxypeptidase A conjugate and activation of methotrexate-phenylalanine. International Journal of Oncology. 24(5). 1289–95. 12 indexed citations

Divgi, Chaitanya, Joseph A. O’Donoghue, Sydney Welt, et al.. (2004). Phase I clinical trial with fractionated radioimmunotherapy using 131I-labeled chimeric G250 in metastatic renal cancer.. PubMed. 45(8). 1412–21. 66 indexed citations

Welt, Sydney, Gerd Ritter, Clarence Williams, et al.. (2003). Preliminary report of a phase I study of combination chemotherapy and humanized A33 antibody immunotherapy in patients with advanced colorectal cancer.. PubMed. 9(4). 1347–53. 31 indexed citations

Welt, Sydney, Gerd Ritter, Clarence Williams, et al.. (2003). Phase I study of anticolon cancer humanized antibody A33.. PubMed. 9(4). 1338–46. 66 indexed citations

Jungbluth, Achim A., Elisabeth Stockert, Hongyi Huang, et al.. (2003). A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor. Proceedings of the National Academy of Sciences. 100(2). 639–644. 141 indexed citations

Noguchi, Yuji, Takashi Saika, Toshiro Ono, et al.. (2001). Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade.. PubMed. 61(12). 4671–4. 108 indexed citations

10.

Rader, Christoph, Gerd Ritter, Sheila Nathan, et al.. (2000). The Rabbit Antibody Repertoire as a Novel Source for the Generation of Therapeutic Human Antibodies. Journal of Biological Chemistry. 275(18). 13668–13676. 100 indexed citations

11.

Ritter, Gerd, Leonard Cohen, Edouard C. Nice, et al.. (1997). Characterization of Posttranslational Modifications of Human A33 Antigen, a Novel Palmitoylated Surface Glycoprotein of Human Gastrointestinal Epithelium. Biochemical and Biophysical Research Communications. 236(3). 682–686. 35 indexed citations

12.

Heath, Joan K., Sara J. White, Cameron N. Johnstone, et al.. (1997). The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamily. Proceedings of the National Academy of Sciences. 94(2). 469–474. 153 indexed citations

13.

Livingston, P O, et al.. (1989). Antibody response after immunization with the gangliosides GM1, GM2, GM3, GD2 and GD3 in the mouse. Cancer Immunology Immunotherapy. 29(3). 179–84. 48 indexed citations

14.

Roy, Polly, et al.. (1988). Evidence for genetic relationship between RNA and DNA viruses from the sequence homology of a putative polymerase gene of Bluetongue virus with that of vaccinia virus: conservation of RNA polymerase genes from diverse species. Nucleic Acids Research. 16(24). 11759–11767. 37 indexed citations

15.

Fukusho, Akio, Gerd Ritter, & Polly Roy. (1987). Variation in the Bluetongue Virus Neutralization Protein VP2. Journal of General Virology. 68(11). 2967–2973. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact